Kovid 19 Haberleri


        
 
Haber:
Etiketler:
Yazarın adı:
Yazarın soyadı:


28 Ekim 2021, Perşembe, 12:14 Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021
mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection was 90% for full immunization (≥14 days after second dose) and 80% for partial immunization (≥14 days after first dose but before second dose) in real-world conditions.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=419354

28 Ekim 2021, Perşembe, 12:14 Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic - Nine States, Nigeria, March 31, 2019-September 30, 2020
This report describes a program that increased the number of persons with HIV infections who initiated antiretroviral therapy before and during the COVID-19 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=418930

28 Ekim 2021, Perşembe, 12:14 Symptoms of Anxiety or Depressive Disorder and Use of Mental Health Care Among Adults During the COVID-19 Pandemic - United States, August 2020-February 2021
From August 2020-February 2021, adults with recent symptoms of an anxiety or depressive disorder increased from 36% to 42%. Increases were largest among adults 18-29 years and those with less than a high school education.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=419353

28 Ekim 2021, Perşembe, 12:14 COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons - United States, December 14, 2020−February 14, 2021
This report describes persons who received both doses of a two-dose COVID-19 vaccination series and the interval between the first and second dose among those who were vaccinated.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=418592

28 Ekim 2021, Perşembe, 12:14 Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021
This report describes an analysis of two Connecticut skilled nursing facilities that found partial vaccination, >14 days after the first dose through 7 days after the second dose, with the Pfizer-BioNTech COVID-19 vaccine 63% effective against SARS-CoV-2 infection.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=418593

28 Ekim 2021, Perşembe, 12:14 Notes from the Field: Opioid Overdose Deaths Before, During, and After an 11-Week COVID-19 Stay-at-Home Order - Cook County, Illinois, January 1, 2018-October 6, 2020
This report describes rates of opioid overdose deaths before, during, and after an 11-week stay-at-home order in Illinois during the COVID-19 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=418418

28 Ekim 2021, Perşembe, 12:14 Association of Children's Mode of School Instruction with Child and Parent Experiences and Well-Being During the COVID-19 Pandemic - COVID Experiences Survey, United States, October 8-November 13, 2020
This report describes the effect of the COVID-19 pandemic on child and parent well-being associated to virtual learning.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=418760

28 Ekim 2021, Perşembe, 12:14 First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021
This report describes monitoring, conducted as part of the U.S. vaccination program, which indicates reassuring safety profiles for COVID-19 vaccines.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=416923

28 Ekim 2021, Perşembe, 12:14 Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020
This report describes detection of the B.1.351 variant in Zambia that establishes an epidemiologic linkage between COVID-19 outbreaks in Zambia and South Africa.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=416828

28 Ekim 2021, Perşembe, 12:14 The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020
This report describes the interim recommendation made by the Advisory Committee on Immunization Practices on December 12, 2020, for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=414100